http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Apiiro Unveils AI-Powered Software Graph Visualization to Continuously Uncover Risks and Transform Threat Modeling
-
RACA DAO's $20 Million Donation Supercharges Big Green's Mission, Uniting Kimbal and Elon Musk’s Legacies in Web3
-
BeyondTrust Names Industry Veteran Sean Malone as Chief Information Security Officer
-
Check Point Software Achieves FedRAMP “In Process” Milestone to Deliver AI-Powered Cyber Security Solutions to U.S. Government
-
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
-
Sino Biological Issues Formal Statement Regarding Current Global Tariff Discussions
-
AITX's RAD Announces First ROAMEO Gen 4 Order
-
BTCS Inc. (BTCS) Capitalizes on Market Dislocations to Expand Ethereum Holdings and Staking Operations
-
Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
-
Halozyme to Report First Quarter 2025 Financial and Operating Results
-
Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses
-
BTCS Inc. Capitalizes on Market Dislocations to Expand Ethereum Holdings and Staking Operations
-
Unmatched Long-Term Bladder Preservation for 36 Months in over 80 percent of Responders with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC CIS and Papillary Disease Alone – Best in Disease and Best i
-
Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th
-
Palo Alto Networks Bolsters SASE Capabilities for Modern Workplace
-
Palo Alto Networks (PANW) Introduces Prisma AIRS
-
Palo Alto Networks (PANW) Announces Intent to Acquire Protect AI
-
Palo Alto Networks Introduces Prisma AIRS: the Foundation on which AI Security Thrives
-
Palo Alto Networks Announces Intent to Acquire Protect AI, a Game-Changing Security for AI Company
-
Guardant Health (GH) Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
-
Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer
-
Mainz Biomed (MYNZ) Provides Q1 Corporate Update and Path to FDA Premarket Approval
-
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
-
Innovative Eyewear, Inc (LUCY) Launches Reebok Smart Eyewear
-
Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
-
Bitget Drops Exclusive LALIGA Skins: Trade in Style with Barça, Real Madrid & More
-
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
-
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
-
Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC
-
Space Flight Laboratory (SFL) Announces Key Milestone in Development of Aspera Space Astronomy Microsatellite Mission
-
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
-
Afinida CEO Norman Tipton Retires, Search for Replacement Underway
-
AST SpaceMobile and U.S. National Science Foundation Establish Coordination Agreement Between Satellite and Ground-Based Astronomy Operations
-
Operation HOPE and Financial Literacy for All’s Green Socks Day Takes Place This Week on April 30
-
Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
-
Innovative Eyewear Launches Reebok® Smart Eyewear
-
Bitget Drops Exclusive LALIGA Skins: Trade in Style with Barça, Real Madrid & More
-
Ontario International Airport Authority presents nearly $54,000 to local USO in support of military servicemembers
-
Halozyme Therapeutics (HALO) Announces argenx Received Positive CHMP Opinion for VYVGART
-
Genprex (GNPX) Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
-
ONEPLAYR Makes Football Dreams Reality: Fans Walk Among Legends at the Globe Soccer Awards via Web3
-
Patrick Moran Joins PKF O'Connor Davies as Partner
-
Halozyme Announces argenx Received Positive CHMP Opinion for VYVGART® (efgartigimod alfa) Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
DeFi Technologies' Subsidiary Stillman Digital Strengthens Institutional Access to its Deep OTC Liquidity Through Talos Integration and Strategic Trading Leadership Appointment
-
BitMart Shines at TOKEN2049 Dubai: A Pinnacle Moment of Innovation and Global Impact
-
Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
-
Guardforce AI Reports Full-Year 2024 Financial Results and Provides Business Update
-
Gogoro to Hold Annual General Meeting on May 28, 2025
-
Chroma Sparks Student Innovation at UTA's 2025 Engineering Showcase
-
Krystal Biotech (KRYS) Announces European Commission Approval of VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa

